In vitro anti-mycobacterial effect of pH-responsive niosome loaded with lactoferricin via modulating inflammatory response-associated proteins in alveolar macrophage

Conventional antitubercular drugs for tuberculosis (TB) encounter a serious challenge related to the adverse outcomes caused by extended treatment duration and drug resistance. Thus, developing an innovative platform with effective anti-TB activity would offer more advantages.